Analysis Life Sciences Thank You A closer look at CDER’s new 2024 guidance agenda
Agency IQ
FEBRUARY 12, 2024
Under the FDA’s Good Guidance Practices regulation at 21 CFR 10.115 , the agency is required to annually publish “a list of possible topics for future guidance document development or revision during the next year.” Our review found that CDER is planning several notable new guidances, including one on artificial intelligence.
40 
Let's personalize your content